SECOND AMENDMENT TO SECURITIES PURCHASE AND SECURITY AGREEMENTSecurities Purchase and Security Agreement • March 21st, 2022 • Evofem Biosciences, Inc. • Pharmaceutical preparations • New York
This Second Amendment to Securities Purchase and Security Agreement (this “Second Amendment”) is entered into as of March 21, 2022 (the “Second Amendment Effective Date”) by and among Evofem Biosciences, Inc., a Delaware corporation (the “Company”), 667, L.P., Baker Brothers Life Sciences, L.P. (each, a “Purchaser”, and collectively, the “Purchasers”), and Baker Bros. Advisors LP, as agent and collateral agent for the Purchasers (in such capacity, the “Designated Agent”).
